Document is current
Any future updates will be listed below
-
Authors
Schwartzman, William E.
Jimenez, Michael
Yates, Andrew R.
Armstrong, Aimee K.
Salavitabar, Arash
Hor, Kan K.
Hoerstrup, Simon
Emmert, Maximilian Y.
Shinoka, Toshiharu
Carrillo, Sergio A.
Breuer, Christopher K.
Kelly, John M.
-
Funding
Funding for this research was provided by:
National Institutes of Health (UH3HL148693, UH3HL148693, UH3HL148693, UH3HL148693, UH3HL148693)
U.S. Department of Defense (W81XWH-22-1-0597, W81XWH-22-1-0597, W81XWH-22-1-0597)
- License Information
-
More Information
Article History
Received: 21 November 2022
Accepted: 20 March 2023
First Online: 7 May 2023
Declarations
:
: C.K.B received grant support from Gunze Limited, Humacyte, and LifeMatrix. S.P.H. is a shareholder at Xeltis BV and LifeMatrix AG. M.Y.E. is a shareholder at LifeMatrix AG.
